Bio21 Institute researchers and Institute affiliates collaborate in working towards advancing human health through early diagnosis and discovery of new treatments of infections and related diseases. Research includes:

• Human pathogens

Research groups include: Malcolm McConville (Biochemistry & Molecular Biology);

• Oral health and microbial diseases

Research groups include: Eric Reynolds (Dental Science);

• Gastrointestinal microbiology

Research groups include: Bioscreen (Bio21 Incubator company);

• Viral and autoimmune diseases

Research groups include: Paul Gleeson and Ian van Driel (Biochemistry and Molecular Biology);

• Transmissible prion and related neurotoxic diseases

Research groups include: Andrew Hill (Biochemistry and Molecular Biology); Roberto Cappai and Kevin Barnham (Pathology)

• Sheep pathogens (Centre for Animal Biotechnology, Veterinary Science Faculty)
• Antibiotic synthesis and characterisation

Back to top